Position in TXMD
as of Sep 30, 2026
· filed Oct 8, 2026
Position Value
$60
-$26 QoQ
Shares Held
30
-23.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 2 holders
Holding Since
Mar 2025
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TXMD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Sep 30, 2026Farther Finance Advisors, LLC holds $5,652,044 across 52 Drug Manufacturers - Specialty & Generic names. TXMD ranks #47 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
55,192 | $978,002 | |
| 2 | ZTS |
Zoetis Inc.
|
9,999 | $698,230 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
17,335 | $516,409 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
3,438 | $487,645 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
25,420 | $462,389 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
707 | $383,116 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
16,406 | $357,978 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
7,117 | $326,456 |
All Filings in TXMD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-09-30 | $60 | 30 | Shares | Sole | 2026-10-08 | |
| 2026-06-30 | $86 | 39 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $62 | 31 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $48 | 30 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $32 | 30 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $34 | 30 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $27 | 30 | Shares | Sole | 2025-04-14 | |
| No filing history on record for this holder in this stock. | ||||||